Uccelli A, Laroni A, Ali R, Battaglia MAlberto, Blinkenberg M, Brundin L, Clanet M, Fernandez O, Marriot J, Muraro P, et al. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. Lancet Neurol. 2021;20(11):917-929.